Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
Journal of Endocrinological Investigation|March 27, 2024
Development of diagnostic algorithm for Cushing's syndrome: a tertiary centre experienceA Efthymiadis, H Loo, B Shine, et al.
Journal of Neural Transmission|January 1, 1986
Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depressionH Loo, C Benkelfat, J M Vanelle, et al.
Journal of Psychiatry & Neuroscience : JPN|March 1, 1996
Differences in the natural autoantibody patterns of patients with schizophrenia and normal individualsP Lévy-Soussan, A Berneman, M F Poirier, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 17, 2009
Preattentional processes and disorganization in schizophrenia: Influence of a 6-week risperidone treatmentI Amado, M C Bourdel, C Daban, et al.
Psychopharmacology|January 1, 1986
Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitorsM F Poirier, C Benkelfat, H Loo, et al.
Neurology|January 1, 1985
Dopaminergic receptor sites in human brain: positron emission tomographyJ C Baron, D Comar, E Zarifian, et al.
European Journal of Human Genetics : EJHG|January 15, 1999
Exclusion of the SCN2B gene as candidate for CMT4BA Bolino, M Seri, F Caroli, et al.
Human Psychopharmacology|January 13, 2004
Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteersM F Poirier, A Galinowski, I Amado, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 8, 2010
Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the TomoTherapy HiArt™ systemH Loo, J Fairfoul, A Chakrabarti, et al.
The American Journal of Psychiatry|May 1, 1989
Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 productionF Villemain, L Chatenoud, A Galinowski, et al.
Pageof 18